XBIOTECH INC's ticker is XBIT and the CUSIP is 98400H102. A total of 62 filers reported holding XBIOTECH INC in Q4 2021. The put-call ratio across all filers is 12.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $33,000 | -40.0% | 8,982 | -6.6% | 0.00% | -50.0% |
Q2 2022 | $55,000 | -32.1% | 9,617 | +4.3% | 0.00% | 0.0% |
Q1 2022 | $81,000 | -21.4% | 9,221 | +0.4% | 0.00% | 0.0% |
Q4 2021 | $103,000 | -29.5% | 9,188 | -17.2% | 0.00% | -33.3% |
Q3 2021 | $146,000 | 0.0% | 11,092 | +25.4% | 0.00% | +50.0% |
Q2 2021 | $146,000 | -3.9% | 8,846 | -1.3% | 0.00% | -33.3% |
Q1 2021 | $152,000 | -33.0% | 8,963 | -37.0% | 0.00% | -40.0% |
Q4 2020 | $227,000 | -26.3% | 14,232 | -12.4% | 0.01% | -50.0% |
Q3 2020 | $308,000 | +156.7% | 16,239 | +93.7% | 0.01% | +150.0% |
Q2 2020 | $120,000 | – | 8,385 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtus ETF Advisers LLC | 15,872 | $273,000 | 0.12% |
WINTON GROUP Ltd | 16,373 | $281,000 | 0.02% |
CAXTON ASSOCIATES LP | 10,309 | $177,000 | 0.02% |
CAAS CAPITAL MANAGEMENT LP | 58,047 | $997,000 | 0.01% |
ALPS ADVISORS INC | 52,932 | $909,000 | 0.01% |
McIlrath & Eck, LLC | 753 | $13,000 | 0.01% |
Russell Investments Group, Ltd. | 119,464 | $2,050,000 | 0.00% |
ETF MANAGERS GROUP, LLC | 8,963 | $152,000 | 0.00% |
ExodusPoint Capital Management, LP | 12,811 | $220,000 | 0.00% |
SYNOVUS FINANCIAL CORP | 11,796 | $203,000 | 0.00% |